Abstract:
INTRODUCTION:Anti-ganglioside antibodies (AGA) have been associated with several peripheral neuropathies, such as Miller-Fisher syndrome, Guillain-Barré syndrome and multifocal motor neuropathy. They have also been studied in patients with systemic lupus erythematosus (SLE), focusing on neuropsychiatric manifestations and peripheral neuropathy, but the results are contradictory. OBJECTIVE:To study the presence of AGA in a large cohort of patients with SLE and neuropsychiatric manifestations. PATIENTS AND METHODS:Serum from 65 consecutive patients with SLE and neuropsychiatric manifestations, collected from 1985 to 2009, was tested for the presence of AGA antibodies (GM1, GM2, GM3, asialo-GM1 GD1a, GD1b, GD3, GT1b, GQ1b) using a standard enzyme-linked immunosorbent assay ELISA test (INCAT 1999) and thin layer chromatography (TLC). RESULTS:Positive results for asialo-GM1 (IgM) were found in 10 patients, 6 were positive for asialo-GM1 (IgM and IgG), and 4 were positive for other AGA such as GM1, GM2, GM3, GD1b, GT1b, GD3, (mainly IgM). CONCLUSIONS:Clinical and statistical studies showed no correlation between AGA and neuropsychiatric manifestations of SLE. Although some patients showed reactivity to AGA, these antibodies are not a useful marker of neuropsychiatric manifestations in SLE patients.
journal_name
Lupusjournal_title
Lupusauthors
Labrador-Horrillo M,Martinez-Valle F,Gallardo E,Rojas-Garcia R,Ordi-Ros J,Vilardell Mdoi
10.1177/0961203312436856subject
Has Abstractpub_date
2012-05-01 00:00:00pages
611-5issue
6eissn
0961-2033issn
1477-0962pii
0961203312436856journal_volume
21pub_type
杂志文章相关文献
LUPUS文献大全abstract::In prospective studies, increased levels of cardiolipin-biding antibodies and autoantibodies to oxidized low-density lipoprotein (LDL) have been observed in patients with myocardial infarction (MI). These findings suggest that antiphospholipid antibodies may contribute to the development of MI. The 'oxidative-modifica...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/096120339800700229
更新日期:1998-01-01 00:00:00
abstract:BACKGROUND:Environmental factors appear to play a role in the pathogenesis of lupus erythematosus (LE). OBJECTIVE:To determine the association between cigarette smoking and various types of cutaneous LE. DESIGN:Retrospective descriptive study at a dermatology clinic of a tertiary referral hospital. METHODS:All patie...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203314559630
更新日期:2015-06-01 00:00:00
abstract:INTRODUCTION:Complement activation is central to the pathogenesis of lupus nephritis (LN). Low serum complement C3 and C4, are traditionally used as markers of lupus disease activity in general and LN in particular. In this study we prospectively measured plasma and urine C3d and C4d, degradation products of C3 and C4 ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320950019
更新日期:2020-11-01 00:00:00
abstract::Systemic lupus erythematosus (SLE) is an immune-mediated disease that is responsive to suppression or modulation of the immune system. Patients with SLE who experience persistent multiorgan dysfunction, despite standard doses of intravenous cyclophosphamide (Cy), represent a subset of patients at high risk of early de...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/0961203304lu491oa
更新日期:2004-01-01 00:00:00
abstract::Rheumatoid Arthritis (RA) is a chronic disease with significant morbidity and functional disability. The traditional treatment for RA relied on the use of NSAIDs early in the disease course, followed by disease-modifying agents later. More recently, the disease-modifying anti-rheumatic drugs (DMARDs) have become the m...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:
更新日期:1996-06-01 00:00:00
abstract:OBJECTIVE:To investigate the relationship between antimalarials (AM) and elevated muscle enzymes in systemic lupus erythematosus (SLE). PATIENTSMETHODS:325 lupus patients with abnormal creatine phosphokinase (CPK) for at least two consecutive clinic visits were enrolled; 54 patients on statins/fibrates (n = 43) and/or...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203315617845
更新日期:2016-04-01 00:00:00
abstract::In the 9-year period between 1982 and 1991, 137 patients attending a medical clinic of Queen Elizabeth Hospital, Hong Kong, were diagnosed as having systemic lupus erythematosus according to the American Rheumatism Association's criteria for classification. The female-to-male ratio was 16 to 1. Commonly the onset age ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339300200207
更新日期:1993-04-01 00:00:00
abstract::Cardiac involvement in systemic lupus erythematosus (SLE) is well documented. The pericardium, myocardium and endocardium, as well as the coronary arteries, the valves and the conduction system can all be affected. While pericarditis is common, arrythmias are less frequently described.We present a 13-year-old male, wh...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320974091
更新日期:2020-11-20 00:00:00
abstract::Although challenging, developing evidence-based approaches to an early and accurate diagnosis of systemic lupus erythematosus is a key approach to preventing disease and lupus-associated morbidity and mortality. Advances in our understanding of preclinical and incomplete lupus erythematosus have enabled the identifica...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203316640367
更新日期:2016-07-01 00:00:00
abstract:OBJECTIVE:The aim of our study was to investigate the efficacy of adipose-derived stem cells (ADSC) transplantation in systemic lupus erythematosus (SLE) and to determine the mechanism of ADSC transplantation. METHODS:B6.MRL/lpr mice were administered ADSC intravenously every week from age 28 to 31 weeks, while the lu...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203318819131
更新日期:2019-02-01 00:00:00
abstract::The antiphospholipid or Hughes syndrome is the association between antiphospholipid antibodies (aPL), venous and arterial thromboses and pregnancy morbidity. Antiphospholipid syndrome (APS) commonly coexists with autoimmune diseases usually systemic lupus erythematosus (SLE), when it is known as secondary APS. When pr...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/0961203302lu179cr
更新日期:2002-01-01 00:00:00
abstract::Objective Genetic variants in FH (complement factor H) were reported to associate with susceptibility to systemic lupus erythematosus (SLE). This study proposed that the genetic defects of FH in the susceptibility and in the development of lupus nephritis might be different. Methods This study enrolled 334 lupus nephr...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203317702254
更新日期:2017-10-01 00:00:00
abstract:BACKGROUND:In a previous study performed 9 ± 3.6 years ago, 74 asymptomatic patients with systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS) underwent lung function testing. A significantly low diffusion capacity (DLCO) ranging from 45% to 70% was recorded in 28 of the 74 (37.8%) patients who wer...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203314566633
更新日期:2015-08-01 00:00:00
abstract::We report a case of drug-induced lupus erythematosus (DILE) secondary to trimethoprim/sulfamethoxazole (TMP/SMX) in a patient with underlying inflammatory bowel disease (IBD). The initial presentation was with febrile pleural and pericardial effusions followed by cardiac tamponade. The patient was treated with a short...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203316657435
更新日期:2017-03-01 00:00:00
abstract::The objective of this study is to investigate the presence of anti-nucleosome (anti-NCS) and anti-chromatin (anti-CRT) antibodies in patients with cutaneous lupus erythematosus (CLE) compared with active and inactive systemic lupus erythematosus (SLE). A total of 154 subjects were evaluated: 54 patients presenting CLE...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203308096255
更新日期:2009-03-01 00:00:00
abstract:INTRODUCTION:High-mobility group box 1 protein (HMGB-1) has been implicated in the pathogenesis of lupus nephritis (LN). There is increased HMGB-1 expression in the kidneys and increased levels are observed in serum and urine of patients with LN. This study was performed to determine whether the increased urinary HMGB-...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203316644331
更新日期:2016-12-01 00:00:00
abstract::We performed a retrospective study of all systemic lupus erythematosus (SLE) pregnancies during a two-year period (2006-2007) to describe the clinical features, maternal and foetal outcomes in our centre. There were 17 pregnancies in 16 women with SLE. Our patients have a mean age of 28.31 years (SD 5.24) and a mean d...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203308096661
更新日期:2009-03-01 00:00:00
abstract::In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstra...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339200100410
更新日期:1992-08-01 00:00:00
abstract:OBJECTIVES:Impaired function of polymorphonuclear cells (PMNs) in systemic lupus erythematosus (SLE) leads to severe gram-positive and gram-negative bacterial infection, and to major morbidity and mortality. Few studies have focused on the association of impaired function of PMNs and SLE patients' susceptibility to inf...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203312474704
更新日期:2013-03-01 00:00:00
abstract:BACKGROUND:We established a multi-centre online registry for primary Sjögren's syndrome (pSS) in China, and compared Chinese patients with those from other countries. METHODS:Data were from 87 rheumatology centres in 27 provinces. All 2986 patients had pSS according to the 2002 American-European Consensus Group or the...
journal_title:Lupus
pub_type: 杂志文章,多中心研究
doi:10.1177/0961203319889666
更新日期:2020-01-01 00:00:00
abstract::The use of TNF alpha (TNFalpha) inhibitors has made a strong impact on the management of rheumatoid and psoriatic arthritis, ankylosing spondylitis and Crohn disease. Side effects of these agents include the development of autoantibodies and a lupus-like syndrome (drug-related lupus, DRL). Here, a case of a patient wh...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203308093922
更新日期:2009-02-01 00:00:00
abstract::In a 76-week, randomized controlled trial, patients received 100 mg LJP 394 or placebo weekly for 16 weeks followed by three 12-week treatment cycles of 50 mg LJP 394 or placebo weekly each separated by eight-week periods when no therapy was administered. Health-related quality of life (HRQOL) was assessed using SF-36...
journal_title:Lupus
pub_type: 临床试验,杂志文章,多中心研究,随机对照试验
doi:10.1191/0961203303lu440oa
更新日期:2003-01-01 00:00:00
abstract::Twelve systemic lupus erythematosus (SLE) patients with mild to moderate disease activity (SLEDAI of > or = 6 and on prednisolone < 0.5 mg/kg/day) were included in a prospective, randomized, double-blind, placebo-controlled pilot study for 24 weeks. Six were randomized to receive oral leflunomide and six received plac...
journal_title:Lupus
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1191/0961203304lu1067sr
更新日期:2004-01-01 00:00:00
abstract::We have previously shown that elevation of anticardiolipin antibodies (aCL) at the first prenatal visit is associated with increased fetal loss in normal pregnancy. The variation in aCL levels during normal pregnancy has not been established. To examine this question we measured IgG, IgM and IgA aCL levels five times ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339500400506
更新日期:1995-10-01 00:00:00
abstract::Objectives The aim of this study was to study the relationship between immunosuppressive drug treatment and survival in patients with systemic lupus erythematosus (SLE). Methods Patients who fulfilled four or more American College of Rheumatology criteria for SLE were followed longitudinally. Clinical characteristics,...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203317739129
更新日期:2018-04-01 00:00:00
abstract:BACKGROUND:This study aimed to investigate whether early eradication therapy influences systemic lupus erythematosus (SLE) risk in patients with Helicobacter pylori (HP) infection. METHODS:We identified 41,653 patients with HP infection in Taiwan from 2000 to 2013. The patient population was divided into early (within...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320923393
更新日期:2020-06-01 00:00:00
abstract::The contribution of the p53 Arg72Pro polymorphism in the development of systemic lupus erythematosus (SLE) remains controversial. We investigated the frequency of the p53 Arg72Pro genotype in patients with SLE (n = 155) and in controls (n = 150) in Poland. We found a weak contribution of the Arg/Arg genotype to the mo...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203307084722
更新日期:2008-02-01 00:00:00
abstract::Several studies have investigated the potential of various autoantibody tests in the diagnosis of systemic lupus erythematosus (SLE). Many lupus patients initially present with glomerulonephritis. In that clinical situation the main differential diagnosis are other forms of glomerulonephritis. In this study the diagno...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203309345753
更新日期:2009-12-01 00:00:00
abstract::Peripheral T cell apoptosis is upregulated in active SLE, in parallel with high expression of both membrane-bound and soluble (s) Fas. Previous studies postulated that sFas down-regulates apoptosis in vitro through its blockade of the Fas-L of cytotoxic cells. We have investigated the extent of apoptosis and sFas leve...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/0961203303lu250oa
更新日期:2003-01-01 00:00:00
abstract::The p53 tumour suppressor is the central regulator of apoptosis. Previously, the functional TP53 Arg72Pro polymorphism was found to be associated with systemic lupus erythematosus (SLE) in Koreans but not Spaniards. MDM2 is the major negative regulator of p53. An intronic polymorphism in MDM2, the SNP309, attenuates p...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203308094558
更新日期:2009-01-01 00:00:00